NCT07089550View on ClinicalTrials.gov

PSMA PET for Treatment Response evaLuation of systemIC Therapies in prostAte caNcer (PELICAN)

RecruitingOBSERVATIONAL
Enrollment

1,300

Participants

Timeline

Start Date

April 2, 2025

Primary Completion Date

April 26, 2034

Study Completion Date

April 26, 2034

Conditions
PSMA Positive Tumors or Tumor TissuesProstate Cancer Metastatic
Interventions
RADIATION

PSMA PET/CT scan

All Patients undergoing PSMA PET for pre-treatment disease staging with different radiotracers (\[68Ga\]Ga-PSMA-11, \[18F\]-DCFPyL, \[18F\]-PSMA-1007).

Trial Locations (4)

12100

RECRUITING

Azienda Ospedaliera Santa Croce e Carle - ospedale Santa Croce, Cuneo

16131

NOT_YET_RECRUITING

U.O. Medicina Nucleare, IRCCS Ospedale Policlinico San Martino, Genova

40138

RECRUITING

Nuclear Medicine, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna

98125

NOT_YET_RECRUITING

UOC Medicina Nucleare, AOU Policlinico G.Martino, Messina

All Listed Sponsors
collaborator

Ospedale Policlinico San Martino

OTHER

collaborator

Ospedale Santa Croce-Carle Cuneo

OTHER

collaborator

"Azienda Ospedaliera Universitaria Policlinico G. Martino"

OTHER

lead

IRCCS Azienda Ospedaliero-Universitaria di Bologna

OTHER